DOI QR코드

DOI QR Code

Bisphosphonate-related osteonecrosis of the jaw in a multiple myeloma patient: A case report with characteristic radiographic features

  • Lee, Byung-Do (Department of Oral and Maxillofacial Radiology and Wonkwang Dental Research Institute, College of Dentistry, Wonkwang University) ;
  • Park, Moo-Rim (Department of Internal Medicine, School of Medicine, Wonkwang University) ;
  • Kwon, Kyung-Hwan (Department of Oral and Maxillofacial Surgery, College of Dentistry, Wonkwang University)
  • Received : 2015.03.14
  • Accepted : 2015.05.24
  • Published : 2015.09.30

Abstract

A 59-year-old male who had suffered from multiple myeloma for nine years and had been administered bisphosphonates for seven years visited a dental hospital for pain relief due to extensive caries in his left maxillary molars. The molars were extracted, leaving an exposed wound for three months. The radiograph showed sequestra formation and irregular bone destruction in the left maxilla. Sudden pain and gingival swelling in the right mandibular molar area occurred six months later. The interseptum of the right lower second molar was observed to be necrotic during surgery. These findings coincided with the features of bisphosphonate-related osteonecrosis of the jaw (BRONJ). In this case, the long intravenous administration of bisphosphonates and tooth extraction were likely the etiologic factors of BRONJ in a patient with multiple myeloma; moreover, the bilateral occurrence of BRONJ is a characteristic feature.

Keywords

References

  1. Kyle RA. Multiple myeloma: review of 869 cases. Mayo Clin Proc 1975; 50: 29-40.
  2. Batsakis JG. Pathology consultation. Plasma cell tumors of the head and neck. Ann Otol Rhinol Laryngol 1983; 92: 311-3. https://doi.org/10.1177/000348948309200320
  3. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995; 45: 8-30. https://doi.org/10.3322/canjclin.45.1.8
  4. Holland J, Trenkner DA, Wasserman TH, Fineberg B. Plasmacytoma. Treatment results and conversion to myeloma. Cancer 1992; 69: 1513-7. https://doi.org/10.1002/1097-0142(19920315)69:6<1513::AID-CNCR2820690633>3.0.CO;2-X
  5. Kyle RA. Diagnostic criteria of multiple myeloma. Hematol Oncol Clin North Am 1992; 6: 347-58. https://doi.org/10.1016/S0889-8588(18)30348-4
  6. Lee SH, Huang JJ, Pan WL, Chan CP. Gingival mass as the primary manifestation of multiple myeloma: report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 75-9. https://doi.org/10.1016/S1079-2104(96)80380-5
  7. Epstein JB, Voss NJ, Stevenson-Moore P. Maxillofacial manifestations of multiple myeloma. An unusual case and review of the literature. Oral Surg Oral Med Oral Pathol 1984; 57: 267-71. https://doi.org/10.1016/0030-4220(84)90182-8
  8. Lambertenghi-Deliliers G, Bruno E, Cortelezzi A, Fumagalli L, Morosini A. Incidence of jaw lesions in 193 patients with multiple myeloma. Oral Surg Oral Med Oral Pathol 1988; 65: 533-7. https://doi.org/10.1016/0030-4220(88)90135-1
  9. Mondello P, Pitini V, Arrigo C, Mondello S, Mian M, Altavilla G. Necrotizing fasciitis as a rare complication of osteonecrosis of the jaw in a patient with multiple myeloma treated with lenalidomide: case report and review of the literature. Springerplus 2014; 3: 123. https://doi.org/10.1186/2193-1801-3-123
  10. Coleman R, Gnant M, Morgan G, Clezardin P. Effects of bone-targeted agents on cancer progression and mortality. J Natl Cancer Inst 2012; 104: 1059-67. https://doi.org/10.1093/jnci/djs263
  11. Lee SH, Chan RC, Chang SS, Tan YL, Chang KH, Lee MC, et al. Use of bisphosphonates and the risk of osteonecrosis among cancer patients: a systemic review and meta-analysis of the observational studies. Support Care Cancer 2014; 22: 553-60. https://doi.org/10.1007/s00520-013-2017-y
  12. Utreja A, Almas K, Javed F. Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update. Odontostomatol Trop 2013; 36: 38-46.
  13. Sukpanichnant S, Cousar JB, Leelasiri A, Graber SE, Greer JP, Collins RD. Diagnostic criteria and histologic grading in multiple myeloma: histologic and immunohistologic analysis of 176 cases with clinical correlation. Hum Pathol 1994; 25: 308-18. https://doi.org/10.1016/0046-8177(94)90204-6
  14. Blade J, Kyle RA, Greipp PR. Multiple myeloma in patients younger than 30 years. Report of 10 cases and review of the literature. Arch Intern Med 1996; 156: 1463-8. https://doi.org/10.1001/archinte.1996.00440120125014
  15. Matsumura S, Kishino M, Ishida T, Furukawa S. Radiographic findings for solitary plasmacytoma of the bone in the anterior wall of the maxillary sinus: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89: 651-7. https://doi.org/10.1067/moe.2000.105349
  16. Croucher PI, Apperley JF. Bone disease in multiple myeloma. Br J Haematol 1998; 103: 902-10. https://doi.org/10.1046/j.1365-2141.1998.01082.x
  17. Mozaffari E, Mupparapu M, Otis L. Undiagnosed multiple myeloma causing extensive dental bleeding: report of a case and review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 448-53. https://doi.org/10.1067/moe.2002.125201
  18. Yaegaki K, Kameyama T, Takenaka M, Kimura T, Sujaku C, Tanimura A. Myelomatosis (IgD, lambda) discovered by oral manifestation. Int J Oral Surg 1985; 14: 381-4. https://doi.org/10.1016/S0300-9785(85)80029-6
  19. Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 2006; 24: 945-52. https://doi.org/10.1200/JCO.2005.04.2465
  20. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007; 65: 369-76. https://doi.org/10.1016/j.joms.2006.11.003
  21. Assael LA. New foundations in understanding osteonecrosis of the jaws. J Oral Maxillofac Surg 2004; 62: 125-6. https://doi.org/10.1016/j.joms.2003.11.009